12 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

History 0 7 25 32 O
of 8 10 33 35 O
drug 11 15 36 40 O
- 15 16 40 41 O
induced 16 23 41 48 O
psoriasis 24 33 49 58 B-chronic_disease
or 34 36 59 61 O
pustular 37 45 62 70 B-chronic_disease
psoriasis 46 55 71 80 I-chronic_disease

Pregnant 0 8 81 89 B-pregnancy

Psoriatic 0 9 90 99 O
group 10 15 100 105 O
only 16 20 106 110 O
: 20 21 110 111 O
Chronic 22 29 112 119 B-chronic_disease
plaque 30 36 120 126 I-chronic_disease
psoriasis 37 46 127 136 I-chronic_disease
( 47 48 137 138 O
patients 48 56 138 146 O
must 57 61 147 151 O
have 62 66 152 156 O
diagnosis 67 76 157 166 O
for 77 80 167 170 O
at 81 83 171 173 O
least 84 89 174 179 O
6 90 91 180 181 B-lower_bound
months 92 98 182 188 I-lower_bound
) 98 99 188 189 O
or 100 102 190 192 O
guttate 103 110 193 200 O
psoriasis 111 120 201 210 O
involving 121 130 211 220 O
2 131 132 221 222 B-lower_bound
% 133 134 223 224 I-lower_bound
or 135 137 225 227 O
greater 138 145 228 235 O
total 146 151 236 241 O
body 152 156 242 246 O
surface 157 164 247 254 O
area 165 169 255 259 O
or 170 172 260 262 O
2 173 174 263 264 O
plaques 175 182 265 272 O
, 182 183 272 273 O
each 184 188 274 278 O
measuring 189 198 279 288 O
> 199 200 289 290 O
8 201 202 291 292 B-lower_bound
cm2 203 206 293 296 I-lower_bound

Psoriatic 0 9 297 306 O
group 10 15 307 312 O
only 16 20 313 317 O
: 20 21 317 318 O
Psoriasis 22 31 319 328 B-chronic_disease
is 32 34 329 331 O
untreated 35 44 332 341 O
( 45 46 342 343 O
as 46 48 343 345 O
defined 49 56 346 353 O
in 57 59 354 356 O
Exclusion 60 69 357 366 O
criteria 70 78 367 375 O
4 79 80 376 377 O
) 80 81 377 378 O
or 82 84 379 381 O
subject 85 92 382 389 O
has 93 96 390 393 O
been 97 101 394 398 O
on 102 104 399 401 O
a 105 106 402 403 O
stable 107 113 404 410 O
topical 114 121 411 418 O
or 122 124 419 421 O
systemic 125 133 422 430 B-treatment
treatment 134 143 431 440 I-treatment
with 144 148 441 445 O
no 149 151 446 448 O
dose 152 156 449 453 O
alteration 157 167 454 464 O
or 168 170 465 467 O
regimen 171 178 468 475 B-clinical_variable
alteration 179 189 476 486 I-clinical_variable
for 190 193 487 490 O
> 194 195 491 492 O
12 195 197 492 494 B-lower_bound
months 198 204 495 501 I-lower_bound

Psoriatic 0 9 502 511 O
group 10 15 512 517 O
only 16 20 518 522 O
: 20 21 522 523 O
Use 22 25 524 527 O
of 26 28 528 530 O
biologic 29 37 531 539 B-treatment
treatment 38 47 540 549 I-treatment
for 48 51 550 553 O
psoriasis 52 61 554 563 B-chronic_disease
within 62 68 564 570 O
3 69 70 571 572 B-upper_bound
months 71 77 573 579 I-upper_bound
of 78 80 580 582 O
baseline 81 89 583 591 O

history 0 7 592 599 O
of 8 10 600 602 O
diabetes 11 19 603 611 B-chronic_disease
mellitus 20 28 612 620 I-chronic_disease

thyroid 0 7 621 628 B-chronic_disease
disease 8 15 629 636 I-chronic_disease
or 16 18 637 639 O
inflammatory 19 31 640 652 B-chronic_disease
bowel 32 37 653 658 I-chronic_disease
disease 38 45 659 666 I-chronic_disease

use 0 3 667 670 O
of 4 6 671 673 O
systemic 7 15 674 682 B-treatment
immunosuppressive 16 33 683 700 I-treatment
treatment 34 43 701 710 I-treatment
for 44 47 711 714 O
psoriasis 48 57 715 724 B-chronic_disease
within 58 64 725 731 O
4 65 66 732 733 B-upper_bound
weeks 67 72 734 739 I-upper_bound
of 73 75 740 742 O
baseline 76 84 743 751 O
, 84 85 751 752 O
or 86 88 753 755 O
use 89 92 756 759 O
of 93 95 760 762 O
topical 96 103 763 770 B-treatment
treatment 104 113 771 780 I-treatment
for 114 117 781 784 O
psoriasis 118 127 785 794 O
within 128 134 795 801 O
2 135 136 802 803 B-upper_bound
weeks 137 142 804 809 I-upper_bound

